[Comment] Cretostimogene grenadenorepvec: promise beyond response | ClinicLens
For patients with high-risk, BCG-unresponsive, non-muscle-invasive bladder cancer with carcinoma in situ, therapeutic decision making remains challenging. Radical cystectomy offers the most reliable oncological control, but at the cost of major surgery, urinary diversion, and las
Medical Literature · Updated
← Back to articlesIf the embedded page does not load in your browser, open it directly.